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The negative regulation of adaptive immunity is relevant to maintain lymphocyte home-
ostasis. Several studies on natural killer (NK) cells have shown a previously unappreci-
ated immunomodulatory role, as they can negatively regulate T cell-mediated immune
responses by direct killing and by secretion of inhibitory cytokines. The molecular mecha-
nisms of T cell suppression by NK cells, however, remained elusive. Only in the last few
years has it become evident that, upon activation, humanT cells express MICA–B, ULBP1–
3, and PVR, ligands of the activating receptors NKG2D and DNAM-1, respectively. Their
expression renders T cells targets of NK cell lysis, representing a new mechanism taking
part to the negative regulation of T cell responses. Studies on the expression of NKG2D
and DNAM-1 ligands on T cells have also contributed in understanding that the activa-
tion of ATM (ataxia-telangiectasia, mutated)/ATR (ATM/Rad3-related) kinases and the DNA
damage response is a common pathway regulating the expression of activating ligands
in different types of cells and under different conditions. The functional consequences of
NKG2D and DNAM-1 ligand expression on activatedT cells are discussed in the context of
physiologic and pathologic processes such as infections, autoimmunity, and graft versus
host disease.
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Natural killer (NK) cells contribute to the suppression of T cell
responses and to the maintenance of T lymphocyte homeostasis
through the release of inhibitory cytokines, such as TGF-β and
IL-10, which can inhibit dendritic cell (DC) maturation or T cell
activation and functions, and/or through the direct elimination
of antigen-presenting cells and activated T cells (Andoniu et al.,
2008). The activating receptors expressed by NK cells and involved
in the direct eliminationof T cells remain still elusive although they
have been recently focus of intense research. 2B4/CD244, LFA-1/-
CD11a/CD18,NKp46/CD335,NKp30/CD337,KIR2DS1/CD158h,
and in particular NKG2D/CD314 and DNAM-1/CD226 appear to
play a prominent role.
EXPRESSION OF NKG2D AND DNAM-1 LIGANDS ON T CELLS
NKG2D AND ITS LIGANDS
NKG2D is an activating receptor expressed on NK cells, CD8+ T
cells and γ/δ T cells that binds to several inducible self-proteins
belonging to the MIC (MICA, MICB) and ULBP (ULBP1 to
ULBP6) families in humans, andH60 (a–c), Rae (α-ε) andMULT1
in mice (Eagle and Trowsdale, 2007). NKG2D ligands (NKG2DLs)
are mainly induced on the surface of transformed, infected or
otherwise “stressed” cells, while the expression on healthy cells
is low. However, increasing evidences show that NKG2DLs can be
constitutively expressed or induced on normal hematopoietic cells
including bone marrow cells (Nowbakht et al., 2005; Poggi et al.,
2005; Spaggiari et al., 2006), mature DCs (Jinushi et al., 2003a,b;
Andoniou et al., 2005; Schrama et al., 2006; Galazka et al., 2007;
Qiao et al., 2008), monocytes and macrophages (Hamerman et al.,
2004; Nowbakht et al., 2005; Nedvetzki et al., 2007; Kloss et al.,
2008; Schulz et al., 2010), B cells (Nowbakht et al., 2005), and
T cells. In general, NKG2DLs are not expressed by resting T
lymphocytes, but their expression can be induced by different
stimuli (Table 1). The ﬁrst evidence of NKG2DL expression on T
cells came from a study by Molinero et al. (2002) indicating that
human T cells can express MICA in response to alloantigen and
to CD3/CD28 cross-linking. Furthermore, also other NKG2DLs
namely MICA,MICB, and ULBP1–3, but not ULBP4, are detected
on both CD4+ and CD8+ T lymphocytes following stimulation
with alloantigens, SEB superantigen, a speciﬁc antigenic peptide or
upon PMA/ionomycin treatment (Cerboni et al., 2007a, 2009). As
a consequence, activated T cells become susceptible to autologous
NK cell lysis, with an NKG2D/NKG2DL-dependent mechanism
(Cerboni et al., 2007a). Nielsen et al. (2012) further demonstrated
that NKG2D, LFA-1, and NKp46 are involved in NK cell degranu-
lation triggered by activated autologous CD4+ T cells, with both
subsets of humanNKcells (CD56dim andCD56bright) equally cyto-
toxic. Expression of NKG2DLs was described also on regulatory
T cells (Treg) in response to Mycobacterium tuberculosis and NK-
cell mediated lysis of Treg involves both NKG2D and NKp46 (Roy
et al., 2008). Expression of NKG2DLs was also reported on acti-
vated murine T cells. H60 is up-regulated on T cells upon in vitro
stimulation with ovalbumin and T cell blasts become susceptible
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Table 1 | Different stimuli implicated in the induction or up-regulation of NKG2D and DNAM-1 ligands on activatedT cells.
Stimulus NKG2DLs DNAM1Ls T cell type Reference
Human anti-CD3 plus anti-CD28 MICA/B,
ULBP1–3
PVR T cells Molinero et al. (2002),
Nielsen et al. (2012)
Superantigen, alloantigen, PMA/
ionomycine, antigenic peptide
MICA/B,
ULBP1–3
CD4+ and
CD8+ T cells
Cerboni et al. (2007a),
Cerboni et al. (2009)
Anti-CD3 plus IL-2 MICA CD8+ T cells Maasho et al. (2005)
Superantigen PVR, Nectin-2 T cells Ardolino et al. (2011)
PHA PVR CD4+ T cells Cella et al. (2010)
Histone deacetylase inhibitors MICA/B Jurkat and activated
T cells
Skov et al. (2005)
Propionic acid MICA/B Jurkat and activated
CD4+ T cells
Andresen et al. (2009)
M. tuberculosis ULBP-1 Treg Roy et al. (2008)
HIV MICA,
ULBP-1, 2,3
Jurkat and activated
CD4+ T cells
Cerboni et al. (2007b),
Ward et al. (2007)
HIV PVR Activated CD4+ T cells Matusali et al. (2012)
Mouse mHA antigen H60, MULT1 CD4+ T cells Noval Rivas et al. (2010)
ConA, PMA/ionomycine, ovalbumin H60 T cells Rabinovich et al. (2003)
to syngeneic NK cell killing (Rabinovich et al., 2003). Of note, an
in vivo study showed that chronic antigenic stimulation of CD4+
T lymphocytes determined up-regulation of H60 and MULT1 lig-
ands (Noval Rivas et al., 2010). NKG2DL expression was observed
on thymocytes of BALB/c mice and was modulated during thymo-
cyte development, suggesting a possible but yet undeﬁned function
in this process (Li et al., 2005). In support of these ﬁndings, a role
for NK cell-mediated cytotoxicity during thymocyte development
was demonstrated (Schott et al., 2003).
DNAM-1 AND ITS LIGANDS
DNAM-1/CD226 is an activating receptor belonging to the Ig
superfamily and is constitutively expressed by most NK cells, T
cells, macrophages, and DCs. DNAM-1 interacts with LFA-1,
required for its functional activity on both NK and cytotoxic T
cells (Shibuya et al., 1996). Ligands for DNAM-1 (DNAM1Ls)
include Nectin-2/CD112 and PVR/CD155 belonging to the
Nectin/Nectin-like family of adhesion molecules (Bottino et al.,
2003; Tahara-Hanaoka et al., 2004). The activating effects of
DNAM-1 can be counteracted by TIGIT, a recently identiﬁed
inhibitory receptor binding to PVR, and expressed by T and NK
cells (Stanietsky et al., 2009). DNAM1Ls are broadly distributed on
hematopoietic, epithelial, and endothelial cells as well as on several
tumors (Bottino et al., 2003; Pende et al., 2006; Tahara-Hanaoka
et al., 2006). We have shown that PVR and Nectin-2 are induced
on T cells in response to SEB stimulation at both the mRNA and
protein levels, but only PVR can reach the cell surface (Ardolino
et al., 2011). PVR expression on CD4+ T lymphocytes was also
observed upon phytohemagglutinin (PHA) stimulation or co-
engagement of CD3/CD28 molecules (Cella et al., 2010; Nielsen
et al., 2012; Table 1). DNAM-1/PVR axis is involved in the NK
cell-mediated lysis of allogeneic activated T cells (Ardolino et al.,
2011), while in an autologous setting, NKG2D emerges as the
dominant receptor (Rabinovich et al., 2003; Cerboni et al., 2007a;
Nielsen et al., 2012).
ROLE OF THE DDR IN THE REGULATION OF NKG2D AND DNAM-1
LIGANDS ON ACTIVATED T LYMPHOCYTES
NKG2DL expression is tightly regulated at various levels. During
malignant transformation, cells undergo genotoxic or other forms
of cellular stress with de novo expression of NKG2DLs. Gasser
et al. (2005) demonstrated that murine and human NKG2DLs
are up-regulated in ﬁbroblasts by genotoxic stress and stalled
DNA replication, conditions known to activate the DNA damage
response (DDR) initiated byATM (ataxia-telangiectasia,mutated)
or ATR (ATM/Rad3-related) kinases. Studies aimed at investi-
gating the signaling pathways leading to NKG2DL expression on
antigen-activated T cells highlighted a role for the DDR as well.
Treatment with ATM/ATR inhibitors blocked MICA induction
on T cells with a mechanism involving NF-κB (Cerboni et al.,
2007a), which regulates MICA expression on activated T lym-
phocytes by binding a speciﬁc sequence in the long intron 1 of
the MICA gene (Molinero et al., 2004). NKG2DLs were found
also on HIV-infected CD4+ T cells and their expression requires
the activation of the DDR and stress pathways, via the HIV-1-
encoded molecule Vpr (Ward et al., 2009; Richard et al., 2010;
Pham et al., 2011), a potent activator of ATR and of a cell cycle
arrest in G2 (He et al., 1995; Jowett et al., 1995; Re et al., 1995;
Roshal et al., 2003). Similarly, oxidative stress and DDR strongly
contribute to induce PVR expression on activatedT cells (Ardolino
et al., 2011). Thus, activation of ATM/ATR kinases and DDR
could be a common pathway regulating the expression of different
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activating ligands on T lymphocytes. Of note, we also found that
genotoxic stress triggered ATM/ATR-dependent up-regulation
of both DNAM1Ls and NKG2DLs on multiple myeloma cells
(Soriani et al., 2009).
Increasing evidences show the involvement of DDR in many
physiological processes, such as mitosis (Oricchio et al., 2006),
insulin response (Yang and Kastan, 2000), V(D)J recombina-
tion (Chen et al., 2000) or after lipopolysaccharide stimulation in
macrophages (Eissmann et al., 2010). In addition, up-regulation
of ATM protein levels was observed in PBMCs (peripheral blood
mononuclear cells) in response to mitogenic stimuli (Fukao et al.,
1999). Increased phosphorylation of either ATM or one of its sub-
strates, the histone H2AX, was described on T cells upon CD3
triggering, PHA or SEB stimulation (Cerboni et al., 2007a; Tanaka
et al., 2007;Ardolino et al., 2011). Remarkably, PVRandNKG2DLs
expression was mainly observed on T cells that had gone through
at least one mitosis (Cerboni et al., 2007a, 2009; Ardolino et al.,
2011). This is only one of the numerous examples showing a
correlation of either NKG2DL or PVR expression with cell pro-
liferation. In murine bone marrow grafts, Rae-1 was detected
on donor proliferating hematopoietic cells in the spleen of the
transplant recipients rather than on the long-term hematopoietic
stem cells (Ogasawara et al., 2005). The presence of MICmolecules
on rheumatoid arthritis synoviocytes was strongly associated with
the expression of the nuclear Ki-67 proliferation marker (Groh
et al., 2003) and MIC gene promoter contains elements for cell
proliferation-associated transcriptional activation (Venkataraman
et al., 2007). A preferential expression of PVR on proliferating
rat hepatocytes during liver regeneration and acute injury was
previously described (Erickson et al., 2006). These authors also
reported that PVR expression in epithelial cells was tightly reg-
ulated by changes in cell density. NK cells react more efﬁciently
to concanavalin A-stimulated, proliferating MHC class I-deﬁcient
target cells than to non-activated cells in vitro and in vivo (Correa
et al., 1994) and proliferating T cells become more susceptible to
NK cell killing (Ardolino et al., 2011). In line with these results,
Davis’s group reported that human NK cells bound to cells in
mitosis more effectively than the same cells in other phases of the
cell cycle (Nolte-’t Hoen et al., 2007). Thus, we envisage that the
expression of PVR and NKG2DLs on proliferating T lymphocytes
is a possible mechanism used by NK cells to restrict the expansion
of activated/proliferating T cells (Figure 1).
FIGURE 1 | NKG2D and DNAM-1 ligands are expressed on
activated/proliferatingT cells. RestingT cells do not express ligands
of the activating receptors NKG2D and DNAM-1 and are resistant to NK
cell-mediated killing. However, uponT cell activation triggered by different
stimuli (listed inTable 1), as well as upon HIV-1 infection, MICA/B,
ULBP1–3, and PVR become detectable on the cell surface, preferentially on
T lymphocytes that were undergone at least one cell division. The
signaling pathways regulating the expression of NKG2D and DNAM-1
ligands involve the activation of ATM/ATR and of their substrates
(e.g., phosphorylation of the histone H2AX). The ﬁnal outcome
is the direct elimination of activated/proliferating T lymphocytes by
NK cells.
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IN VIVO RELEVANCE FOR NK–T CELL INTERACTION
VIRAL INFECTIONS
A plethora of studies analyzed the role of NKG2D/NKG2DL
axis by looking at infected cells, which very often express one
or more ligands. These studies have demonstrated that NKG2D
plays an important role in anti-viral immunity, via a direct
NK cell-mediated lysis of infected cells. This evidence is also
underscored by the countermeasures taken by viruses to avoid
NKG2D-mediated triggering (Lanier, 2008; Rossini et al., 2012).
However, NK cell contribution to anti-viral immunity can be seen
also from another point of view: NK cells might restrain anti-viral
T cell responses, thus promoting the return to T cell homeostasis.
In vivo depletion studies established that NK cells act to
negatively regulate CD4+ and CD8+ T cell-dependent IFN-γ
production and proliferation during murine cytomegalovirus
infection, and they can mediate a similar effect on CD4+ T cell
responses during lymphocytic choriomeningitis virus (LCMV)
infection in β2-microglobulin deﬁcient mice (Su et al., 2001).
Accordingly, a more recent study showed that perforin-deﬁcient
mice chronically infected with LCMV contain greater numbers of
activated anti-viral T cells compared to control animals. The accu-
mulation of activated CD8+ T cells resulted in mortality within
2–4 weeks, an event which is rarely seen following an i.p. injec-
tion with LCMV of normal mice (Matloubian et al., 1999). It was
described also a three-way of NK–T cell interaction, where NK
cells directly eliminate activated CD4+ T cells (via a perforin-
dependent pathway), thereby affecting CD8+ T cell function with
beneﬁcial or detrimental effects depending on the viral dose. How-
ever, no role for NKG2D/NKG2DLs could be observed (Waggoner
et al., 2011). In another study, NK cell depletion promoted LCMV-
induced CD8+ T cell immunity with the involvement of both
perforin and NKG2D (Lang et al., 2012). Altogether, these studies
show that NK cells can be crucial in controlling viral infections
not only by a direct elimination of infected cells, but also by alter-
ing the number and functions of virus-speciﬁc T cells. However,
the role of NKG2D and other activating receptors awaits a better
elucidation.
ConsideringHIV-1, a virus replicating (among other cell types)
in CD4+ T lymphocytes, we face a situation where NK cell
targeting of activated T cells via NKG2D means, at the same
time, eliminating the infected cell. In fact, expression of sev-
eral NKG2DLs was observed on HIV-1 infected CD4+ T cells,
with increased susceptibility to NK lysis (Cerboni et al., 2007b;
Ward et al., 2007; Fogli et al., 2008; Richard et al., 2010). How-
ever, HIV-1 has also evolved its own countermeasures as it can
also down-regulate NKG2DLs via Nef and Vif proteins (Cerboni
et al., 2007b; Norman et al., 2011). Thus, regulation of NKG2DL
expression by Vpr, Nef and possibly other viral proteins might
have different impacts on NK cell recognition of infected CD4+
T cells.
The role of DNAM-1 and its ligands in the context of NK–T
cell interactions during viral infections has been less investi-
gated. Recently, PVR was detected on HIV-1 infected CD4+ T
cells, and when the NKG2D pathway was inhibited, additional
blocking of DNAM-1 strongly impaired the capacity of NK cells
to kill HIV-1-infected cells, indicating the involvement of both
receptors (Matusali et al., 2012). However, expression of PVR on
CD4+ T cells might also be responsible for the down-regulation of
DNAM-1 on CD8+ T cells observed in chronic HIV-1 infection
(Cella et al., 2010).
AUTOIMMUNITY
The mechanisms by which NK cells modulate adaptive immune
responses in the course of autoimmune diseases have been
addressed by a large number of in vivo and in vitro studies.
However, depending on the model system, NK cells might either
promote or inhibit the generation and proliferation of autoreac-
tive T cells (French and Yokoyama, 2004; Shi and Van Kaer, 2006;
Flodström-Tullberg et al., 2009; Lünemann et al., 2009).
Thinking in terms of negative regulation of (autoreactive)
T cell responses, NK cells might exert a direct effect on acti-
vated, autoantigen-speciﬁc T cells. In experimental autoimmune
encephalomyelitis (EAE), in vivo depletion of NK cells exacerbated
demyelination and the clinical features of EAE; in addition, in vitro
studies have shown that direct NK–T cell contact inhibited T cell
proliferation and cytokine production triggered bymyelin-derived
peptides (Zhang et al., 1997; Matsumoto et al., 1998; Smeltz et al.,
1999; Xu et al., 2005). NK cells might thus ameliorate the course
of EAE by limiting the expansion of myelin-reactive T cells in the
periphery and in the absence of their suppressive action, central
nervous system inﬂammation became more marked. However,
these studies are in conﬂict with another report showing that NK
cell depletion resulted in less severe clinical scores (Shi et al., 2000).
In an in vivo model of colitis, NK cell-depleted animals developed
accelerated disease, and it was suggested that NK cells inhibited
effector CD4+ T cells in a perforin-dependent manner (Fort et al.,
1998; Yamaji et al., 2012). Such a protective effect also occurred in
Staphylococcus aureus- and collagen-induced arthritis (CIA; Nils-
son et al., 1999; Leavenworth et al., 2011), as well as in NOD mice
(Lee et al., 2004).
A number of studies have identiﬁed the cytolytic mechanism
underlying NK cell-mediated killing of autoreactive T cells, and
the NK cell-mediated immunoregulatory activity was shown to
be perforin-dependent in animal models of colitis, EAE, and CIA
(Fort et al., 1998; Lu et al., 2007; Leavenworth et al., 2011). Thus,
the receptor/ligand interactions triggering a perforin-mediated
cytotoxicity play a key role in controlling T cell responses, and
NKG2D might be part of the picture, since it plays a major role
in NK cell lysis of autologous activated T cells (Rabinovich et al.,
2003; Cerboni et al., 2007a; Nielsen et al., 2012). Moreover, NK
cells can lyse autologous DCs, that under certain circumstances
– including EAE – express NKG2DLs (Jinushi et al., 2003a,b;
Andoniou et al., 2005; Schrama et al., 2006; Galazka et al., 2007;
Qiao et al., 2008). These data, together with NKG2DL expres-
sion also on activated macrophages and monocytes, bone marrow
cells and microglia (Lünemann et al., 2008), indicate that this
receptor/ligand pair might play a more general immunoregula-
tory role besides killing autoreactive T cells, e.g., by eliminating
macrophages and other antigen-presenting cells or their precur-
sors under inﬂammatory conditions, as a feedback mechanism to
silence uncontrolled antigen-speciﬁc immune responses.
The role of NKG2D/NKG2DLs in autoimmunity has been
addressed also from another point of view. In fact, endogenous
cells and/or tissues can aberrantly express NKG2DLs (as shown in
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particular for MICA and MICB in humans and Rae-1 in mice),
promoting activation of autoreactive inﬁltrating NKG2D+ T cells,
leading to tissue destruction. Examples of this condition can be
found in human type I diabetes and in NOD mice, in patients
with rheumatoid arthritis, Crohn’s disease, celiac disease, and in a
mouse model of autoimmune vitiligo. These aspects are however
reviewed elsewhere (Shi and Van Kaer, 2006; Van Belle and von
Herrath, 2009).
Regarding DNAM-1, despite the expression of PVR on acti-
vated T cells (Cella et al., 2010; Ardolino et al., 2011; Nielsen
et al., 2012), its role was not evident in autologous NK–T com-
binations (Ardolino et al., 2011; Nielsen et al., 2012), while it was
relevant in allogeneic settings (Ardolino et al., 2011), suggesting
that DNAM-1 might not be involved in autoimmune reactions.
GRAFT VERSUS HOST DISEASE
Allogeneic bone marrow transplantation (BMT) was estimated
to be an effective treatment for hematologic malignancies and
some solid tumors. However, the high incidence of graft versus
host disease (GVHD) mediated by the activation and prolifer-
ation of alloreactive T cells leads to severe host tissue damage.
Previous studies demonstrated that donor NK cells are able to
suppress the development of GVHD through the killing of host
antigen-presenting cells which are essential for donor T cell
activation (Ruggeri et al., 2002). More recently, several in vivo
studies in the mouse showed a direct effect of donor NK cells
on GVHD-inducing T cells. Allogeneic T cells and NK cells traf-
ﬁcked similarly after BMT (Olson et al., 2009) and donor NK
cells limited the expansion of syngeneic donor T cells through
different mechanisms mediated by perforin and Fas-FasL interac-
tion (Olson et al., 2010). Similarly, in a model of chronic GVHD,
donor NK cells could restrain the expansion of antigen-speciﬁc
CD4+ T cells responsible for GVHD. Interestingly, T cells under
chronic antigenic stimulation up-regulated NKG2DLs and the
immunoregulatory activity of NK cells was inhibited by injec-
tion of antibodies directed to NKG2D (Noval Rivas et al., 2010).
In humans, a fraction of KIR2DS1+ NK cells can mediate strong
alloreactivity against both mDCs and activated T lymphocytes and
DNAM-1 and NKp30 were shown to be involved in this process,
supporting an important role of NK cells in the prevention of
GVHD (Sivori et al., 2011).
CONCLUSION
In summary, a central role for NK cell killing in mediating
immunoregulatory effects is emerging. Studies of different con-
ditions (infections, autoimmunity, transplants) indicate that NK
cytotoxicity of activated T cells, as well as of other cells of the
immune system, is important in immune regulation. The involve-
ment of NKG2D and DNAM-1 receptors may represent the “tip
of the iceberg,” with signiﬁcant effects on the negative regulation
of adaptive T cell responses, resulting in increased viral burdens,
viral persistence, and/or inﬂammation. The locations where these
events take place, and which are the NK cell subsets involved are
still rather obscure parts of the picture.
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